Description: LEARN is an offering to regulators about reinsurance. This article summarizes a session held for Brazilian health regulators in the fall of 2022.

Description: Insurance companies significantly expanded their use of life reinsurance throughout the late '90s and early '00s. This has meant that volumes being ceded to the reinsurance market have continued to expand after a brief respite in 2001 through quota share opportunities with direct insurers keeping only a portion of their published retention.

Description: This article looks at how the underwriting process has transformed from a paper process to become fully online. Not only has the process been digitized, there has been various innovations incorporating technology thus enabling large volume process automation, better customer experience as well as higher closing ratio. Other than improvement on speed and efficiency, various smart solutions are being explored to refine risk management through data mining and analysis of underwriting data.

Description: Cell and Gene Therapy (CGT) are life-changing treatments where conditions such as cancer, hemophilia, spinal muscular atrophy and blindness are being cured. These are great for individuals and society, but the treatment costs are expensive which is bad for payers and reinsurers. This article explores ways for health reinsurance actuaries to participate in the space and evaluate the risk associated with these treatments

Description: The effects of the COVID-19 pandemic have been discussed widely and in depth, with lockdown measures and restrictions on travel and trading having a severe impact on the global economy. It is therefore essential the insurance industry investigates these changes in the economy in terms of their impact on morbidity and mortality. In this article, we highlight some of the key findings on this topic.

Description: Historically low interest rates, historically high equity market volatility and ever increasing life spans have made pension funding a hot topic. Financing the lifestyles of the superannuated through steadily improving investment performance is no longer a given. Market realities and stricter regulatory funding requirements are forcing plan sponsors to reduce overly optimistic assumptions about how well their investments will perform and increase assumptions about how long they will have to last. A growing number of well-known corporations are looking for help in trying to make the math work. This article discusses the opportunities for all who want to take on longevity risk.

Description: Feature article discussing how to bring value to clients seeking reinsurance.

Description: Latest outlook on the market size and recent trends associated with the U.S. and Canada Life Reinsurance markets. The SOA Life Reinsurance Survey is an annual survey that exhibits individual and group life data from U.S. and Canadian life reinsurers. Survey results are based on financial information self-reported by reinsurance entities and include new business production and inforce figures.

Description: Feature article discussing the current state of reinsurance for the variable annuity market.

Description: Feature article focuses on the regulators who determine risk-based capital or RBC standards applicable to health plans.